Because the treatment uses a serum created from your own blood, the risk of an allergic reaction or rejection is virtually zero
In February 2021, the researchers published the findings from their trial in The New England Journal of Medicine, showing that patients using semaglutide lost almost 15% of their body weight, on average, compared with 2.4% among patients who got the placebo
The focus remains on BPC-157 compound identity, COA review, analytical testing, peptide purity, lot traceability, research-use-only labeling, product documentation, and published literature boundaries
Because of these benefits, Sermorelin may be a choice for a variety of people , most notably children and even adults with growth hormone deficiency, as well as those looking for one of its many anti-aging properties